UltraGreen.ai’s big slump: Was it the Singapore market that failed the company, or vice versa?
Companies seeking to be priced on their potential must adopt a culture of transparency and meaningful engagement
UltraGreen.ai, a company seeking to be priced on its potential, found itself in hot water during the National Day weekend. An independent analyst named Jamal Aliyev alerted colleagues to research he had just published, highlighting two companies, Zydus Lifesciences and Provepharm, that may soon compete with UltraGreen.ai in the United States for the supply of indocyanine green (ICG) dye.
Aliyev also noted that UltraGreen.ai had failed to disclose recent regulatory approvals obtained by these potential competitors in the crucial US market.
Written by urgent.news from The Business Times - Companies & Markets's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
